share_log

A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts

A Glimpse Into The Expert Outlook On AbbVie Through 7 Analysts

通过7位分析师的观点了解艾伯维公司的专家前景
Benzinga ·  07/02 14:00
7 analysts have expressed a variety of opinions on AbbVie (NYSE:ABBV) over the past quarter, offering a diverse set of opinions from bullish to bearish.
过去一个季度,7位分析师对AbbVie (NYSE:ABBV)发表了不同的看法,从看好到看淡意见不一。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
总结他们最近的评估,下表展示了过去30天内不断变化的情绪,并将其与之前的几个月进行了比较。
Analysts have recently evaluated AbbVie and provided 12-month price targets. The average target is $190.29, accompanied by a high estimate of $200.00 and a low estimate of $180.00. Observing a downward trend, the current average is 1.4% lower than the prior average price target of $193.00.
分析师近期评估了AbbVie并提供了12个月的价格目标。平均目标为190.29美元,伴随着最高200.00美元和最低180.00美元的估计。当前的平均值比之前的平均价格目标193.00美元降低了1.4%。
Interpreting Analyst Ratings: A Closer Look
解读分析师评级:更深入的了解
A clear picture of AbbVie's...
通过对最近分...
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发